Final Continuous Glucose Monitor (CGM) Policy Released

Published in Home Medical Equipment on March 07, 2023

Final Continuous Glucose Monitor (CGM) Policy ReleasedThis article was originally written by The van Halem Group

Medicare released the final draft of the new Glucose Monitor LCD and Policy Article with an effective date of April 16, 2023. The change was completed after a response to comments for the LCD. This new policy revamps the current CGM coverage criteria with some highlights below.

Initial Coverage

The beneficiary for whom a CGM is being prescribed can be insulin treated or non-insulin treated with additional criteria.

  • The beneficiary is insulin-treated; or,
  • The beneficiary has a history of problematic hypoglycemia with documentation of at least one of the following:
    • Beneficiaries with non-insulin treated diabetes and a history of recurrent (more than one) level 2 hypoglycemic events.
  • The treating practitioner must document at least one of the following in the medical record for each event: 
    • The glucose values for the qualifying event(s) (glucose <54mg/dL (3.0mmol/L)); or,
    • Classification of the hypoglycemic episode(s) as level 2 event(s); or,
    • Incorporate a copy of the beneficiary’s BGM testing log into the medical record reflecting the specific qualifying events (glucose <54mg/dL (3.0mmol/L)); and,
    • Documentation of more than one previous medication adjustment and/or modification to the treatment plan (such as raising A1c targets) prior to the most recent level two event.
  • Beneficiaries with non-insulin treated diabetes and a history of at least one level 3 hypoglycemic event
  • The treating practitioner must document at least one of the following in the medical record:
    • The glucose value for the qualifying event (glucose <54mg/dL (3.0mmol/L)); or,
    • Classification of the hypoglycemic episode as level 3 event; or,
    • Incorporate a copy of the beneficiary’s BGM testing log into the medical record reflecting the specific qualifying event (glucose <54mg/dL (3.0mmol/L)); and,
    • An indication in the medical record that the beneficiary required third party assistance for treatment.

They also added the language that patient evaluations with the treating practitioner can be in-person or Medicare-approved telehealth visit with the beneficiary.

Continued Coverage

Coverage criteria for continued coverage notes “the treating practitioner conducts an in-person or Medicare-approved telehealth visit with the beneficiary to document adherence to their CGM regimen and diabetes treatment plan every six (6) months following the initial prescription for CGM. Medicare indicated that there is no requirement for the treating practitioner to reconfirm the initial coverage are met for continued coverage.

Modifiers

For blood glucose monitors (codes E0607, E2100, E2101) and related supplies (codes A4233, A4234, A4235, A4236, A4244, A4245, A4246, A4247, A4250, A4253, A4255, A4256, A4257, A4258, A4259) and CGM devices (code E2102 or E2103) and supply allowance (code A4238 or A4239), the following modifiers must be added to the code(s) on every claim submitted:

  • Use modifier KX if the beneficiary is insulin treated; or,
  • Use modifier KS if the beneficiary is non-insulin treated.

Contact The van Halem Group at info@vanhalemgroup.com for any questions.


TAGS

  1. medicare
  2. vgm
  3. wound care

From Our Experts

Advancements in Respiratory Technology: Shaping the Future of Patient Care thumbnail Advancements in Respiratory Technology: Shaping the Future of Patient Care The field of respiratory care is rapidly evolving, driven by technological innovations that promise better patient outcomes and enhanced quality of life. Breaking Into the Wound Care Space: How to be Successful in the Dressings Market thumbnail Breaking Into the Wound Care Space: How to be Successful in the Dressings Market To be successful in the wound care market, consider this five-step approach to breaking into the wound care space. Why Rent When I Can Own? thumbnail Why Rent When I Can Own? Why would a provider want to rent their ventilator fleet rather than own their own assets? It all boils down to risk and investments. To own a ventilator rental fleet can be incredibly expensive. Beyond the acquisition cost, warehousing space, inventory tracking, preventative maintenance, property insurance, and risk mitigation should be considered when factoring in the purchase price of equipment. How many ventilators are currently in your warehouse? Fisher & Paykel Healthcare launches revolutionary F&P Solo™ Nasal mask for obstructive sleep apnea in the United States. thumbnail Fisher & Paykel Healthcare launches revolutionary F&P Solo™ Nasal mask for obstructive sleep apnea in the United States. Fisher & Paykel today announced the launch of the F&P Solo™ Nasal mask in the USA for the treatment of obstructive sleep apnea (OSA). Understanding Compression Therapy: A Vital Approach for Wound Management for Venous Insufficiency and Lymphedema thumbnail Understanding Compression Therapy: A Vital Approach for Wound Management for Venous Insufficiency and Lymphedema There are various kinds of compression that can be used to treat wounds in the wound care field. Wound Care Essentials: Choosing the Right Medical Tape thumbnail Wound Care Essentials: Choosing the Right Medical Tape We may not realize it, but medical tapes are an essential part of proper wound care. When it comes to tape, where do we start? Inventory Tracking Solutions for High-Value Assets with myTrace thumbnail Inventory Tracking Solutions for High-Value Assets with myTrace In today's episode of Industry Matters, Respiratory Edition – In today's episode, Boone Lockard, VP of Clinical Services with VGM & Associates talks with Greg Apostolou, President and CEO, and Elliot Campbell, EVP and Chief Commercial Officer with Trace Medical on their new myTrace device and how this device can be integral in high-value asset tracking and inventory management. They also discuss ventilator rentals and biomed services. Meet Direct Supply® – Bringing Innovation to the HME Industry thumbnail Meet Direct Supply® – Bringing Innovation to the HME Industry In today's episode, Dave Lyman, Senior Vice President of Sales for VGM & Associates talks with our vendor partner, Direct Supply. Dave and Nick Bush, Director of Business Development for Direct Supply, discuss supply chain reliability, creating outrageous customer service, and the importance of innovation and technology.